|
Volumn 8, Issue 4, 2002, Pages 237-243
|
Infliximab improves quality of life in patients with Crohn's disease
|
Author keywords
Antitumor necrosis factor therapy; Crohn's disease; Crohn's disease activity index; Inflammatory bowel disease; Inflammatory Bowel Disease Questionnaire; Infliximab; Quality of life
|
Indexed keywords
AMINOSALICYLIC ACID DERIVATIVE;
AZATHIOPRINE;
CORTICOSTEROID;
CYCLOSPORIN;
INFLIXIMAB;
MERCAPTOPURINE;
MESALAZINE;
METHOTREXATE;
PLACEBO;
PREDNISONE;
ADULT;
AGED;
ANGER;
ANXIETY;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROHN DISEASE;
DEFECATION;
DEPRESSION;
DISEASE ACTIVITY;
DOUBLE BLIND PROCEDURE;
DRUG INFUSION;
DRUG RESPONSE;
EMOTION;
ENERGY;
FATIGUE;
FEMALE;
FRUSTRATION;
HUMAN;
LEISURE;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
PATIENT SATISFACTION;
PRIORITY JOURNAL;
QUALITY OF LIFE;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
SCORING SYSTEM;
SOCIAL ASPECT;
SPORT;
TREATMENT OUTCOME;
WELLBEING;
WORK;
|
EID: 0036066936
PISSN: 10780998
EISSN: None
Source Type: Journal
DOI: 10.1097/00054725-200207000-00001 Document Type: Article |
Times cited : (140)
|
References (20)
|